Women's health Clinical Trials in Austin, TX
As of July 2026, 35 paid clinical trials are recruiting for Women's health in Austin, Texas. Recruiting Women's health studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Austin
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
36 clinical trials for Women's health
·Clear filters·↓ Download CSVStudy to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
Sample Collection for Ongoing Research and Product Evaluation Study
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Cognitive Processing Therapy (CPT) for Perinatal Posttraumatic Stress Disorder (PTSD)
The Periviable GOALS Decision Support Tool
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Maternal Abdominal Morphology Assessment
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
SprmPik AI Sperm Selection Study SiD, an Assistant for Sperm Selection During Intracytoplasmic Sperm Injection in Medically Assisted Reproduction: Effect on Fertilization, Blastocyst Formation, Early Pregnancy Loss, and Consistent Practice. A Prospective Pilot Study.
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
About research studies in Austin
Austin has approximately 679 recruiting research studies across a wide range of therapeutic areas. Texas hosts major cancer and cardiovascular research centers including MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and the Texas Medical Center — the largest medical complex in the world.
Top Research Study Locations in Austin
Researchers run research studies in Austin, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Dell Children's Medical Center of Central Texas | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Down Syndrome | 35 |
| University of Texas at Austin | Stroke, Alcohol Drinking, Alzheimer Disease | 20 |
| The University of Texas at Austin | Attention Deficit Hyperactivity Disorder, Healthy, Multiple Sclerosis | 19 |
| FutureSearch Trials of Neurology | Obesity, Osteoarthritis, Knee, Chronic Pain | 14 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, HIV Infections, Influenza, Human+COVID-19 | 11 |
| Dell Children's Medical Center | AAOCA, Acute Treatment of Migraine, Adolescent Idiopathic Scoliosis | 11 |
| Texas Cardiac Arrhythmia Research Foundation | Atrial Fibrillation, Heart Failure, Paroxysmal AF | 11 |
| Austin Heart | Heart Failure, Obesity, Heart Failure With Preserved Ejection Fraction | 10 |
| NEXT Austin | Advanced Solid Tumors, Endometrial Cancer, Advanced Solid Tumor | 10 |
| Texas Oncology - Central South | Advanced Renal Cell Carcinoma, Advanced Solid Tumor, Advanced or Metastatic Renal Cell Carcinoma | 9 |
| Texas Oncology - Central/South Texas | Acinar Cell Carcinoma, Advanced Cancer, Advanced Non-Small Cell Lung Cancer | 8 |
| Austin Clinical Trial Partners | Major Depressive Disorder, Depression, Major Depressive Disorder (MDD) | 8 |
| Texas Oncology | Multiple Myeloma, Any Solid Oral Medication, CRC (Colorectal Cancer) | 8 |
| Urology Austin | Non-Muscle Invasive Bladder Neoplasms, Non-muscle Invasive Bladder Cancer With Carcinoma in Situ, Prostate Cancer | 8 |
| Austin Retina Associates | Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD), Age-related Macular Degeneration (AMD) | 7 |
| St. David's South Austin Medical Center | Multiple Myeloma, AML, Acute Biphenotypic Leukemia | 7 |
| Ascension Texas Cardiovascular | Aortic Valve Stenosis, Cardiovascular Diseases, Pulmonary Hypertension | 6 |
| IMA Clinical Research Austin | Obesity, Overweight, Liver Fibrosis | 6 |
| NEXT Oncology | Breast Cancer, Locally Advanced (Unresectable) or Metastatic Solid Tumors, Ovarian Cancer | 6 |
| National Neuromuscular Research Institute | Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis | 6 |
| University of Texas | Logopenic Progressive Aphasia, Logopenic Progressive Aphasia (LPA), Logopenic Variant Primary Progressive Aphasia | 6 |
| Austin Neuromuscular Center | Antiphospholipid Syndrome (APS), Behçet's Syndrome (BS), Bullous Pemphigoid (BP) | 5 |
| Austin Clinical Research, LLC | Diabetic Macular Edema, Geographic Atrophy, Macular Edema | 5 |
| Dell Children's Blood and Cancer Center | Neuroblastoma, Medulloblastoma, Pediatric Cancer | 5 |
| Pinnacle Clinical Research - Austin | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 5 |
Active & Upcoming Studies in Austin (2026)
Recruiting trials in Austin grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (172 active studies)
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors · Phase 1 · Cogent Biosciences, Inc.
- Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence · Phase 4 · Blue Earth Diagnostics
Diabetes & metabolic (51 active studies)
- A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide · Phase 3 · Novo Nordisk A/S
- Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (50 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Mental health & behavior (48 active studies)
- Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD) · Phase 2 · Tonix Pharmaceuticals, Inc.
Cardiovascular (44 active studies)
- Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation · Boston Scientific Corporation
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (24 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
Pediatric (13 active studies)
- Feasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements · Kenneth Moise MD
- Pressure Targeting During High Flow Therapy in Premature Infants · Phase 2 · University of Texas at Austin
Vaccines (3 active studies)
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
- A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults · Phase 1 · GlaxoSmithKline
HIV / STI (3 active studies)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) · Phase 3 · Merck Sharp & Dohme LLC
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV · Phase 1 · ViiV Healthcare
Common conditions studied in Austin
- Obesity (19 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Heart Failure (16 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Overweight (14 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Breast Cancer (13 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Endometrial Cancer (13 active studies). Recruiting Endometrial Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Schizophrenia (13 active studies). Schizophrenia research tests muscarinic agonists, long-acting injectable antipsychotics, and cognitive remediation therapies.
Leading research sponsors in Austin
- University of Texas at Austin
- AbbVie
- AstraZeneca
- Children's Oncology Group
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in Texas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials run in Texas must also comply with the Texas Medical Privacy Act (TMPA), which extends federal HIPAA protections to a broader range of entities handling participant data.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Austin. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Austin
Hipa.ai aggregates every recruiting study in Austin from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Austin?
There are approximately 679 recruiting clinical trials in Austin, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Austin pay participants?
Most recruiting trials in Austin compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Austin?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Austin?
The most common conditions under active study in Austin include Obesity (19), Heart Failure (16), Overweight (14), Breast Cancer (13), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Austin?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Austin on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Austin?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Austin?
Recruiting research sites in Austin include Dell Children's Medical Center of Central Texas, University of Texas at Austin, The University of Texas at Austin, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Austin right now?
The largest active categories in Austin are Cancer & tumors (172), Diabetes & metabolic (51), Neurology & pain (50). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.